Your browser doesn't support javascript.
loading
Analysis on Ethical Issues in Off-label Use of Antitumor Drugs / 中国医学伦理学
Chinese Medical Ethics ; (6): 714-717, 2023.
Article en Zh | WPRIM | ID: wpr-1005656
Biblioteca responsable: WPRO
ABSTRACT
The phenomenon of off-label use of antitumor drugs in the treatment of malignant tumors is relatively common. Although it is conducive to the development of clinical medical practice, but it is still necessary to pay attention to ethical issues such as medication risks and inadequate implementation of informed consent. Therefore, to effectively avoid ethical risks and standardize the rational use of off-label antitumor drugs, this paper proposed that pharmacists should actively participate in the process of off-label use of antitumor drugs, improve the evidence level of evidence-based medicine, implement patients’ right to informed consent, and improve the hospital’s supervision system of off-label drug use, so as to ensure the reasonable and legal use of drugs by patients.
Palabras clave
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Chinese Medical Ethics Año: 2023 Tipo del documento: Article
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Chinese Medical Ethics Año: 2023 Tipo del documento: Article